← back to search

Jun‐ichirou Yasunaga

Kumamoto University Hospital · JP
Area of research
Immunology · Ecology, Evolution, Behavior and Systematics
Research interest
Research interests include T-cell and Retrovirus Studies, Vector-Borne Animal Diseases, Animal Disease Management and Epidemiology, and RNA Interference and Gene Delivery.
h-index
41
citations
6,545
works
332
NIH funding
primary concept
Biology
email

Recent publications

Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphoma.
2026cited by 3position: contributordoi
IL-6-driven POU2AF1 and ELL2 are key regulators of multiple myeloma-distinct transcriptional and splicing programs.
2026cited by 0position: contributordoi
Stratagems of HTLV-1 for persistent infection and the resultant oncogenesis: Immune evasion and clonal expansion.
2025cited by 7position: contributordoi
Evolution of primate T-cell leukemia virus type 1 accessory genes and functional divergence of its antisense proteins.
2025cited by 7position: contributordoi
JunB-HBZ nuclear translocation by TGF-β is a key driver in HTLV-1-mediated leukemogenesis.
2025cited by 3position: contributordoi
A Dendritic Cell-Like Transition of T Cells Is Associated with Spontaneous Remission of Adult T-Cell Leukemia-Lymphoma.
2025cited by 3position: contributordoi
Integrative analysis of ATAC-seq and RNA-seq for cells infected by human T-cell leukemia virus type 1.
2025cited by 3position: contributordoi
Human T-cell leukemia virus type I: modulation of viral gene expression and perturbation of host signaling pathways lead to persistent infection.
2025cited by 2position: contributordoi
Identification of AK4 and RHOC as potential oncogenes addicted by adult T cell leukemia.
2025cited by 2position: contributordoi
Impact of Novel Agents on Allogeneic Hematopoietic Cell Transplantation in Patients with T-Cell Lymphomas.
2025cited by 1position: contributordoi
Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancer.
2025cited by 1position: contributordoi
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.
2025cited by 1position: contributordoi
Identification of Occult Simian T-Cell Leukemia Virus Type 1 Infection in Japanese Macaques.
2025cited by 1position: contributordoi
Validity of the criteria for clinical transformation of follicular lymphoma: analysis of a mostly biopsied cohort.
2025cited by 0position: contributordoi
Dual resistance to cold and ethanol in <i>Penicillium</i> species persistently contaminating donated cadavers
2025cited by 0position: contributordoi
Intra-pol proviral open region of HTLV-1 controls the transcription from both long terminal repeats
2025cited by 0position: contributordoi
Machine learning based characterization of high risk carriers of HTLV-1-associated myelopathy (HAM).
2025cited by 0position: contributordoi
Covalent anti-HIV compound that induces HIV-1 capsid multimerization and degradation decomposes the viral core
2025cited by 0position: contributordoi
Identification of Natural Remission of Mother-to-Child Retroviral Transmission.
2025cited by 0position: contributordoi
Figure S6 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
2025cited by 0position: contributordoi
Figure S5 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
2025cited by 0position: contributordoi
Table S4 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
2025cited by 0position: contributordoi
Figure S3 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
2025cited by 0position: contributordoi
Table S3 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
2025cited by 0position: contributordoi
Supplementary Table S5 from A Dendritic Cell–Like Transition of T Cells Is Associated with Spontaneous Remission of Adult T-Cell Leukemia–Lymphoma
2025cited by 0position: contributordoi
Supplementary Figure 2 from A Dendritic Cell–Like Transition of T Cells Is Associated with Spontaneous Remission of Adult T-Cell Leukemia–Lymphoma
2025cited by 0position: contributordoi
Supplementary Figure 1 from A Dendritic Cell–Like Transition of T Cells Is Associated with Spontaneous Remission of Adult T-Cell Leukemia–Lymphoma
2025cited by 0position: contributordoi
Data from A Dendritic Cell–Like Transition of T Cells Is Associated with Spontaneous Remission of Adult T-Cell Leukemia–Lymphoma
2025cited by 0position: contributordoi
Supplementary Table S2 from A Dendritic Cell–Like Transition of T Cells Is Associated with Spontaneous Remission of Adult T-Cell Leukemia–Lymphoma
2025cited by 0position: contributordoi
Table S1 from HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 138 papers (2020–2026) · 128 papers (2020–2025)Masao Matsuoka · MPC Corporation128 papers (2020–2025)Takafumi Shichijo · Kumamoto University Hospital118 papers (2021–2026)Azusa Tanaka · The University of Tokyo112 papers (2020–2025)Miho Watanabe · Chiba University111 papers (2023–2025)Osama Hussein · Kumamoto University109 papers (2023–2025)Kosuke Toyoda · Public Library of Science101 papers (2021–2025)Wenyi Zhang · Second Hospital of Tianjin Medical University98 papers (2023–2025) · 97 papers (2020–2025)Koichi Ohshima · The Japanese Society of Gastroenterological Surgery97 papers (2020–2025)Yuichiro Arima · Kumamoto University96 papers (2022–2025)Kenichi Tsujita · ATP Clinical Research (United States)95 papers (2023–2025) · 95 papers (2023–2025)Daisuke Kurita · Juntendo University95 papers (2023–2025) · 95 papers (2023–2025)Tarig Salah · 95 papers (2023–2025)Kazutaka Nakashima · 久留米大学95 papers (2023–2025)Kyohei Yamada · Hiroshima University95 papers (2023–2025)Miyu Sonoda · Kumamoto University95 papers (2023–2025)